Compare LUNG & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUNG | VATE |
|---|---|---|
| Founded | 1995 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6M | 70.3M |
| IPO Year | 2020 | 1996 |
| Metric | LUNG | VATE |
|---|---|---|
| Price | $2.54 | $4.54 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.81 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 14.4K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $91,664,000.00 | ★ $1,099,900,000.00 |
| Revenue This Year | $9.21 | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.59 | N/A |
| 52 Week Low | $1.31 | $4.05 |
| 52 Week High | $9.37 | $13.79 |
| Indicator | LUNG | VATE |
|---|---|---|
| Relative Strength Index (RSI) | 71.32 | 32.98 |
| Support Level | $1.96 | $4.76 |
| Resistance Level | $1.74 | $5.28 |
| Average True Range (ATR) | 0.20 | 0.24 |
| MACD | 0.10 | -0.07 |
| Stochastic Oscillator | 91.13 | 24.99 |
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.